November 26, 2024 at 02:59PM Assessment of Ovarian Toxicity in Premenopausal Adults During Drug Development for Oncologic Products

This guidance provides recommendations to sponsors regarding measurement of ovarian toxicity using clinical measures and biomarkers of ovarian function in relevant cancer clinical trials that enroll premenopausal adults

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/D6Isi8x